コンテンツへスキップ
Merck
  • A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript.

A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript.

Human molecular genetics (2014-10-17)
Biswarathan Ramani, Ginny M Harris, Rogerio Huang, Takahiro Seki, Geoffrey G Murphy, Maria do Carmo Costa, Svetlana Fischer, Thomas L Saunders, Guangbin Xia, Richard C McEachin, Henry L Paulson
要旨

Polyglutamine diseases, including spinocerebellar ataxia type 3 (SCA3), are caused by CAG repeat expansions that encode abnormally long glutamine repeats in the respective disease proteins. While the mechanisms underlying neurodegeneration remain uncertain, evidence supports a proteotoxic role for the mutant protein dictated in part by the specific genetic and protein context. To further define pathogenic mechanisms in SCA3, we generated a mouse model in which a CAG expansion of 82 repeats was inserted into the murine locus by homologous recombination. SCA3 knockin mice exhibit region-specific aggregate pathology marked by intranuclear accumulation of the mutant Atxn3 protein, abundant nuclear inclusions and, in select brain regions, extranuclear aggregates localized to neuritic processes. Knockin mice also display altered splicing of the disease gene, promoting expression of an alternative isoform in which the intron immediately downstream of the CAG repeat is retained. In an independent mouse model expressing the full human ATXN3 disease gene, expression of this alternatively spliced transcript is also enhanced. These results, together with recent findings in other polyglutamine diseases, suggest that CAG repeat expansions can promote aberrant splicing to produce potentially more aggregate-prone isoforms of the disease proteins. This report of a SCA3 knockin mouse expands the repertoire of existing models of SCA3, and underscores the potential contribution of alternative splicing to disease pathogenesis in SCA3 and other polyglutamine disorders.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ドデシル硫酸ナトリウム, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
Sigma-Aldrich
ドデシル硫酸ナトリウム, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
ドデシル硫酸ナトリウム 溶液, BioUltra, for molecular biology, 10% in H2O
Sigma-Aldrich
デオキシコール酸ナトリウム, BioXtra, ≥98.0% (dry matter, NT)
Sigma-Aldrich
ドデシル硫酸ナトリウム 溶液, BioUltra, for molecular biology, 20% in H2O
Sigma-Aldrich
ドデシル硫酸ナトリウム, ACS reagent, ≥99.0%
Sigma-Aldrich
ドデシル硫酸ナトリウム, BioUltra, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
抗NeuN抗体 (ウサギ), from rabbit, purified by affinity chromatography
Sigma-Aldrich
デオキシコール酸ナトリウム, ≥97% (titration)
Sigma-Aldrich
ドデシル硫酸ナトリウム, ReagentPlus®, ≥98.5% (GC)
Supelco
ドデシル硫酸ナトリウム, dust-free pellets, suitable for electrophoresis, for molecular biology, ≥99.0% (GC)
SAFC
デオキシコール酸ナトリウム
Sigma-Aldrich
モノクロナール抗MAP2 マウス宿主抗体, clone HM-2, ascites fluid
Sigma-Aldrich
ドデシル硫酸ナトリウム, ≥98.0% (GC)
Sigma-Aldrich
ドデシル硫酸ナトリウム, BioXtra, ≥99.0% (GC)
Sigma-Aldrich
ドデシル硫酸ナトリウム, 92.5-100.5% based on total alkyl sulfate content basis
Sigma-Aldrich
抗脊髄小脳失調3型抗体、クローン1H9, ascites fluid, clone 1H9, Chemicon®
Sigma-Aldrich
ドデシル硫酸ナトリウム, tested according to NF, mixture of sodium alkyl sulfates consisting mainly of sodium dodecyl sulfate
Supelco
ドデシル硫酸ナトリウム, suitable for ion pair chromatography, LiChropur, ≥99.0%
Sigma-Aldrich
ドデシル硫酸ナトリウム, ≥90% ((Assay))
Sigma-Aldrich
ドデシル硫酸ナトリウム, ≥98.0% (GC)
ドデシル硫酸ナトリウム, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
ドデシル硫酸ナトリウム, ≥99.0%
Sigma-Aldrich
ドデシル硫酸ナトリウム, ≥99.0%
Sigma-Aldrich
ドデシル硫酸ナトリウム, SAJ special grade, ≥97.0%
Sigma-Aldrich
ドデシル硫酸ナトリウム, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC), free-flowing, Redi-Dri
Sigma-Aldrich
B6-White Murine ES Cell Line, The generation of gene-modified mice, created by homologous recombination in embryonic stem (ES) cells, has become a fundamental tool for analyzing gene function.
Sigma-Aldrich
ドデシル硫酸ナトリウム, SAJ first grade, ≥95.0%